AFP
HP Ab (Helicobacter pylori Antigen)
-
This product can be used for auxiliary diagnosis of gastric Helicobacter pylori.
-
This product is intended for vitro qualitative determination of Helicobacter pylori Antibody (HP Ab) in human whole blood, serum or plasma.
Rheumatoid factors(RF)
High-sensitivity Cardiac troponin I(Hs-cTnI)
Introducing the hs-cTnI Rapid Quantitative Test, in conjunction with the Aehealth FIA Meter, by AEHEALTH LIMITED. This innovative product is designed for the precise and rapid determination of Cardiac troponin I (cTnI) in human whole blood, serum, or plasma. The high-sensitivity of this test makes it an invaluable tool for the auxiliary diagnosis of myocardial infarction, aiding healthcare professionals in making critical decisions for patient care. The test provides accurate quantitative results, allowing for quick and efficient assessment of cTnI levels. With the Aehealth FIA Meter, the hs-cTnI Rapid Quantitative Test offers a user-friendly and reliable solution for healthcare facilities. Trust in AEHEALTH LIMITED for cutting-edge diagnostic products to support improved patient outcomes.
Insulin
HBsAg (FIA)
- Whether there is hepatitis B virus in the body
- Prediction of antiviral therapy for patients with chronic hepatitis B
HCV (FIA)
- Determine whether the patient has ever been infected with hepatitis C
Dengue NS1 Ag(FIA)
- Whether there is Dengue virus in the body
- Prediction of antiviral therapy for patients with Dengue
P.F/P.V (MALARIA Ag)(FIA)
- Whether there is P.F/P.V(MALARIA Ag) virus in the body
- Prediction of antiviral therapy for patients with P.F/P.V(MALARIA Ag)
P.F/Pan (MALARIA Ag)(FIA)
- Whether there is P.F/Pan(MALARIA Ag) virus in the body
- Prediction of antiviral therapy for patients with P.F/Pan(MALARIA Ag)
Anti-CCP
Rheumatoid arthritis (RA) is the most common inflammatory arthropathy worldwide. It is a chronic, complex, and heterogeneous autoimmune disease (AD).
Identification of RA at initial presentation and treatment at earlier stage can affect disease course, prevent the development of joint erosions or retard progression of erosive disease. Early diagnosis and treatment may affect disease outcomes even to a remission state.